메뉴 건너뛰기




Volumn 18, Issue 1, 2003, Pages 89-100

PRE-dialysis survey on anaemia management

Author keywords

Anaemia management; Best practice guidelines; Epidemiology; Epoetin; Pre dialysis

Indexed keywords

CREATININE; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

EID: 0037234271     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.1.89     Document Type: Article
Times cited : (109)

References (15)
  • 1
    • 0033968567 scopus 로고    scopus 로고
    • Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients
    • Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology
    • Moreno F, Sanz-Guajardo D, Lopez-Gomez JM, Jofre R, Valderrabano F. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol 2000; 11: 335-342
    • (2000) J. Am. Soc. Nephrol. , vol.11 , pp. 335-342
    • Moreno, F.1    Sanz-Guajardo, D.2    Lopez-Gomez, J.M.3    Jofre, R.4    Valderrabano, F.5
  • 2
    • 0031733696 scopus 로고    scopus 로고
    • Clinical epidemiology of cardiovascular disease in chronic renal disease
    • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (Suppl 3): S112-S119
    • (1998) Am. J. Kidney Dis. , vol.32 , Issue.SUPPL. 3
    • Foley, R.N.1    Parfrey, P.S.2    Sarnak, M.J.3
  • 3
    • 0033052842 scopus 로고    scopus 로고
    • Hematocrit level and associated mortality in hemodialysis patients
    • Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10: 610-619
    • (1999) J. Am. Soc. Nephrol. , vol.10 , pp. 610-619
    • Ma, J.Z.1    Ebben, J.2    Xia, H.3    Collins, A.J.4
  • 4
    • 0030921662 scopus 로고    scopus 로고
    • NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
    • National Kidney Foundation-Dialysis Outcomes Quality Initiative
    • National Kidney Foundation-Dialysis Outcomes Quality Initiative. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30 (Suppl 3): S192-S240
    • (1997) Am. J. Kidney Dis. , vol.30 , Issue.SUPPL. 3
  • 5
    • 0032778437 scopus 로고    scopus 로고
    • European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure
    • Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure
    • European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 1999; 14 (Suppl 5): 1-50
    • (1999) Nephrol. Dial. Transplant , vol.14 , Issue.SUPPL. 5 , pp. 1-50
  • 6
    • 0001564209 scopus 로고    scopus 로고
    • European Survey on Anaemia Management (ESAM)
    • European Survey on Anaemia Management (ESAM), Nephrol Dial Transplant 2000; 15 (Suppl 4): 1-76
    • (2000) Nephrol. Dial. Transplant , vol.15 , Issue.SUPPL. 4 , pp. 1-76
  • 8
    • 0033810113 scopus 로고    scopus 로고
    • European best practice guidelines 5: Target haemoglobin
    • Jacobs C, Hörl WH, Macdougall IC et al. European best practice guidelines 5: target haemoglobin. Nephrol Dial Transplant 2000; 15 (Suppl 4): 15-19
    • (2000) Nephrol. Dial. Transplant , vol.15 , Issue.SUPPL. 4 , pp. 15-19
    • Jacobs, C.1    Hörl, W.H.2    Macdougall, I.C.3
  • 9
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
    • (1976) Nephron. , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 10
    • 1642299648 scopus 로고    scopus 로고
    • Excerpts from United States Renal Data System. 1999 Annual Data Report
    • Excerpts from United States Renal Data System. 1999 Annual Data Report. Am J Kidney Dis 1999; 34 (2 Suppl 1): S1-S176
    • (1999) Am. J. Kidney Dis. , vol.34 , Issue.2 SUPPL. 1
  • 11
    • 0032844311 scopus 로고    scopus 로고
    • Healthcare systems-an international review: An overview
    • Lameire N, Joffe P, Wiedeman M. Healthcare systems-an international review: an overview. Nephrol Dial Transplant 1999; 14 (Suppl 6): 3-9
    • (1999) Nephrol. Dial. Transplant , vol.14 , Issue.SUPPL. 6 , pp. 3-9
    • Lameire, N.1    Joffe, P.2    Wiedeman, M.3
  • 12
    • 0032873332 scopus 로고    scopus 로고
    • The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey
    • Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey. Nephrol Dial Transplant 1999; 14 (Suppl 6): 16-23
    • (1999) Nephrol. Dial. Transplant , vol.14 , Issue.SUPPL. 6 , pp. 16-23
    • Lameire, N.1    Van Biesen, W.2
  • 13
    • 0033820211 scopus 로고    scopus 로고
    • European best practice guidelines 1-4: Evaluating anaemia and initiating treatment
    • Valderrabano F, Horl WH, Jacobs C et al. European best practice guidelines 1-4: evaluating anaemia and initiating treatment. Nephrol Dial Transplant 2000; 15 (Suppl 4): 8-14
    • (2000) Nephrol. Dial. Transplant , vol.15 , Issue.SUPPL. 4 , pp. 8-14
    • Valderrabano, F.1    Horl, W.H.2    Jacobs, C.3
  • 14
    • 0032840297 scopus 로고    scopus 로고
    • Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States
    • Obrador GT, Rathazer R, Arora P, Kausz AT, Pereira BJG. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 1999; 10: 1793-1800
    • (1999) J. Am. Soc. Nephrol. , vol.10 , pp. 1793-1800
    • Obrador, G.T.1    Rathazer, R.2    Arora, P.3    Kausz, A.T.4    Pereira, B.J.G.5
  • 15
    • 0036194475 scopus 로고    scopus 로고
    • Epoetin treatment: What are the arguments to expect a beneficial effect on progression?
    • Rossert J, McClellan WM, Roger SD, Verbeelen DL. Epoetin treatment: what are the arguments to expect a beneficial effect on progression? Nephrol Dial Transplant 2002; 17 (3): 359-362
    • (2002) Nephrol. Dial. Transplant , vol.17 , Issue.3 , pp. 359-362
    • Rossert, J.1    McClellan, W.M.2    Roger, S.D.3    Verbeelen, D.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.